Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 10, Issue 6
|
pp. 1424–1441
Usefulness of bevacizumab-induced hypertension in patients with metastatic colorectal cancer: an updated meta-analysis
Back to article
Figure 2
(2 of 4)
−
100%
+
Figure 2.
Overall forest plots of objective response rate (ORR), progression-free survival (PFS) and overall survival (OS) for bevacizumab-induced hypertension in patients with metastatic colorectal cancer.
